Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-RePoRT: Metformin in Rising PSA Prostate Cancer
NCT02376166Completed
- Start
- Jul 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of liquid metformin (Aspargo Labs) in prostate cancer (PCa). Primary endpoint: Number of Participants That Completed All Telemedicine Visits at 6 months. Started Jul 2014; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02376166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376166.